1. Heuer, M.A., Morris, R.W. “Smith Kline & French worldwide clinical experience with auranofin: a review”. In “Auranofin - proceedings of a Smith Kline & French International Symposium”, Amsterdam, 15-16 November 1982. Eds, Capell, H.A., Cole, D.S., Manghani, K.K. and Morris, R.W. Excerpta medica, 1983, 474-449.
2. Mainland, D., Sutcliffe, M.I. Hydroxychloroquine sulphate in rheumatoid arthritis: a six month, double-blind trial. Bull Rheum Fis, 1962, 13, 287–290.
3. Dwosh, I.L., Stein, H.B., Urowitz, M.B., Smythe, H.A., Hunter, T., Ogryzio, M.A. Azathioprine in early rheumatoid arthritis: comparison with gold and chloroquine. Arthritis Rheum, 1977, 20, 685–692.
4. Kirsner, A.B., Sheon, R.P., Finkel, R.I., Farber, S.J. A four year prospective study of gold and anti-malarials in rheumatoid arthritis. Arthritis Rheum, 1979, 22, 630.
5. Bird, H.A.. Le Gallez, P., Dixon, J.S., Sitton, N.G., Wright, V. “Results of a comparative study of auranofin and hydroxychloroquine”. In “Auranofin - proceedings of a Smith Kline & French International Symposium”, Amsterdam, 15-16 November 1982. Eds. Capell, H.A., Cole, D.S., Manghani, K.K., Morris, R.W. Excerpta Medica, pp. 249-261.